Latest News
-
Kolling researcher to join prestigious Harvard Medical School program
Posted on:
Congratulations to Kolling Institute researcher Dr Manasi Mittinty who has been selected for the Advanced Global Clinical Scholar Research training at Harvard Medical School. Dr Mittinty is a medical trained researcher with the Pain Management and Research Centre and a University of Sydney lecturer. She has a keen interest in translation research and the connections
Primary Research Area/s:
-
Researchers confirm extreme heat increases the risk of premature births
Posted on:
Researchers have found that women are more likely to have a preterm birth when exposed to extreme heat and those with pre-existing conditions may have an even higher risk. Preterm or premature birth, when a baby is born before 37 weeks of pregnancy, is the leading cause of infant death worldwide and many children born
Primary Research Area/s:
-
Study confirms deadly risk of COVID-19 for those with heart failure
Posted on:
The largest study of its kind in Australia has found patients with a history of heart failure are three times more likely to die from COVID-19. Launched last year at the outset of the pandemic, the AUS-COVID trial is investigating those who are most at risk from COVID-19 in Australia. To date, it has assessed
Primary Research Area/s:
-
The Kolling’s up and coming talent recognised
Posted on:
Acting Executive Director Professor Jim Elliott has announced the winners of the inaugural Kolling Institute Emerging Leader Awards, saying there’s an inspiring depth of expertise throughout the institute. Professor Elliott said the new awards recognise our young leaders across our basic and translational research, and were initiated by the institute’s Workforce and Culture Enabler Committee.
Primary Research Area/s:
-
Research identifies swallowing problems following whiplash
Posted on:
Research conducted by a team from Kolling Institute has found that swallowing difficulties after a whiplash injury appear to be an under-recognised consequence of the injury. The study investigated a group of 60 patients with low-grade whiplash, finding 50 per cent of patients reported swallowing problems within 12 months of their whiplash injury. In 31
Primary Research Area/s:
-
Researchers reject the use of plasma injections for knee joint osteoarthritis
Posted on:
In what will be disappointing news for many, a large-scale clinical trial has found platelet-rich plasma injections for those with osteoarthritis knee pain are no better than a placebo. This type of injection has become an increasingly popular form of treatment for knee joint arthritis, despite its prohibitive cost at around $2,000 per injection. Plasma
Primary Research Area/s:
-
Blueprint to strengthen research and improve the care we receive
Posted on:
The Kolling’s new research plan has been confirmed marking an important milestone for the institute. The plan details the implementation of the institute’s five-year strategy, and will ensure the Kolling is in the best position to deliver game-changing research. Acting Executive Director Professor Jim Elliott has welcomed the development of the plan, saying a robust
Primary Research Area/s:
-
Kolling researcher takes out coveted award
Posted on:
Congratulations to Kolling researcher Dr Jillian Eyles who’s been named one of the inaugural research translation fellows by Sydney Health Partners. Facing tremendous competition from a large group of outstanding researchers, Jillian is one of just five people to have been awarded a fellowship, which means they’ll be able to dedicate a greater amount of
Primary Research Area/s:
-
High-profile appointment
Posted on:
The Kolling Institute’s Executive Director Professor Carolyn Sue will join a dynamic group of Australian leaders on the new National Health and Medical Research Council. Professor Sue has been appointed to the high profile body for a three-year term until June 2024. A record number of women are represented on the new council, including chair
Primary Research Area/s:
-
Researchers develop new program to reduce medication burden
Posted on:
A team from the Kolling Institute led by Professor Sarah Hilmer has helped develop a valuable, new national program to reduce the adverse impacts of taking multiple medicines. Medicines with an anticholinergic effect can successfully treat many conditions such as depression, dementia and chronic non-cancer pain. Cumulatively however, they can cause serious adverse effects such
Primary Research Area/s:
